Skip to main content
. 2016 Aug 19;21(8):1094. doi: 10.3390/molecules21081094

Figure 9.

Figure 9

The neuroprotective effect of the HLJDT CFP and baicalin–berberine complex assessed by AO/EB staining. (a) Control group; (b) injured by CoCl2; (c) treated with 15 µg/mL HLJDT CFP then injured by CoCl2; and (d) treated with 15 µg/mL baicalin–berberine complex then injured by CoCl2 (×200).